{
  "original_uri": "https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html",
  "self": "http://localhost:1208/timemap/json/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html",
  "mementos": {
    "list": [
      {
        "datetime": "2023-10-11T22:39:50Z",
        "uri": "https://web.archive.org/web/20231011223950/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
      },
      {
        "datetime": "2023-10-12T04:31:05Z",
        "uri": "https://web.archive.org/web/20231012043105/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
      },
      {
        "datetime": "2023-10-12T12:02:49Z",
        "uri": "https://web.archive.org/web/20231012120249/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
      },
      {
        "datetime": "2023-10-19T01:34:56Z",
        "uri": "https://web.archive.org/web/20231019013456/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
      }
    ],
    "first": {
      "datetime": "2023-10-11T22:39:50Z",
      "uri": "https://web.archive.org/web/20231011223950/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
    },
    "last": {
      "datetime": "2023-10-19T01:34:56Z",
      "uri": "https://web.archive.org/web/20231019013456/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
    }
  },
  "timemap_uri": {
    "link_format": "http://localhost:1208/timemap/link/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html",
    "json_format": "http://localhost:1208/timemap/json/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html",
    "cdxj_format": "http://localhost:1208/timemap/cdxj/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
  },
  "timegate_uri": "http://localhost:1208/timegate/https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html"
}
